Author

Beate Timmerman

Observed names: B Timmerman, B. Timmerman

Institution: Essen University Hospital

Observed institutions: University of Wisconsin–Madison, University of California, Los Angeles, Institut Gustave Roussy, Paul Scherrer Institute, Thompson Cancer Survival Center, Essen University Hospital, Indiana University Indianapolis, Deutsches Konsortium für Translationale Krebsforschung, Stiftung Universitätsmedizin Essen, University of Duisburg-Essen

OpenAlex ID: A5020710037

Sensitivity of intensity modulated proton therapy plans to changes in patient weight

2008 · Francesca Albertini, Alessandra Bolsi, et al. · Radiotherapy and Oncology · 69

Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN

2018 · Damien C. Weber, Jean Louis Habrand, et al. · Radiotherapy and Oncology · 65

New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue‐sparing techniques

2007 · Francis L Munier, Jorn Verwey, et al. · Clinical and Experimental Ophthalmology · 65

Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group

2023 · S. Gaito, E.J. Hwang, et al. · Clinical Oncology · 29

Phase IB/II trial of the radiation sensitizer gadolinium texaphyrin (Gd-Tex) for patients with brain metastases: Final results

1998 · B Timmerman, P Carde, et al. · International Journal of Radiation Oncology*Biology*Physics · 8

Improving Access to Proton Therapy in the United States and Around the World

2024 · Derek S. Tsang, Beate Timmerman · International Journal of Radiation Oncology*Biology*Physics · 5

Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy

2023 · Paul D. Aridgides, Anita Mahajan, et al. · Pediatric Blood & Cancer · 4

Selective uptake and retention of the radiation sensitizer gadolinium texaphyrin (Gd-Tex) in tumors demonstrated by MRI in phase I and II clinical trials

1998 · C Kesserling, M Renschler, et al. · International Journal of Radiation Oncology*Biology*Physics · 3

Gct-08. the Pursuit of Optimum Treatment for Nongerminomatous Germ Cell Tumours (nggct) of the Cns – a Progress Report From the European Group (siop Cns Gct Ii)

2024 · James C Nicholson, Claire Alapetite, et al. · Neuro-Oncology · 2

An overview of the European standard clinical practice recommendations for choroid plexus tumours

2025 · David King, Brigitte Bison, et al. · EJC Paediatric Oncology · 1

Pharmacokinetics of the radiation sensitizer gadolinium texaphyrin in a phase IB/II trial for patients with brain metastases receiving whole brain radiation

1998 · M Egorin, D Miles, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Outcomes of Children With Orbital Rhabdomyosarcoma, 1991–2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT)

2026 · Jonathan Metts, James Anderson, et al. · Pediatric Blood & Cancer

Local Control of Bladder/Prostate Rhabdomyosarcoma: An Expert Consensus Guideline From the International Soft Tissue Sarcoma Consortium (INSTRuCT)

2026 · Daniel J. Indelicato, Amanda F. Buchanan, et al. · Pediatric Blood & Cancer

Works count: 13

Citation count: 252

H-index: 5

I10-index: 4